Translate:
EN
Translate:
EN
Signed in as:
filler@godaddy.com
Our research teams are constantly involved in the development of innovative eye, ENT and skincare medicines originating from India. Our DSIR & FDA approved international formulation R&D facilities provide us with the technologies to develop and design the highest quality indigenous therapies and continuously innovate. Our research teams consist of some of the most experienced pharmaceutical scientists & chemists from India engaging in new drug development, formulation research and clinical trials.
We are also actively investing in generative AI-led drug discovery, quality analysis and a clinical trial programme, and intend to be a pioneer in robotic process automation in sterile manufacturing. Our clinical trial programme includes plans for various phase 2, phase 3 and phase 4 trials over the coming years. The investments already made and planned for new drug development and clinical trials should allow us to rapidly commercialise new and innovative therapeutic molecules in India that are the need of the hour.
Developed an eye drop used to slow down myopia (short-sightedness) in children and help keep their “minus number” in check.
Developed an eye drop that for treatment of presbyopia in adults.
Developed antibiotic eye injection used at the end of the cataract eye removal procedure to prevent infections post-surgery and improve safety. This injection has drastically improved surgery safety across the length and breath of the country.
Developed an eye injection used during cataract removal surgery that keeps the eye dilated during the procedure, reduces immediate post-operative pain and cuts down surgery and waiting times for patients. This injection is used routinely in most cataract surgeries performed in the country today and has significantly improved the experience of patients undergoing cataract surgery.
Development of a specialised plant-based antioxidant supplement to improve hearing and promote good ear health.
Development of a micellar formulation in a spray form for ear wax removal.
Development of an electrolytic artificial saliva spray
Development of an anti-allergy probiotic for a healthier nasal flora.
Development of an adaptogeniccognitive performance enhancer to help boost memory, mood, focus and reduce brain fog.
Developed a proprietary neurotoxin-based facial gel serum to help reduce fine lines and expression wrinkles in early ageing skin. This novel concept allows for an injection-FREE approach to achieving younger looking skin that’s affordable, safe and clinically proven.
Development of a nanotechnology based under eye gel serum to boost skin under the eyes and help tackle under eye dark circles.
Development of a 3D Moisturising Facial Gel Cream
Development of a silicone-based ultra matte sunscreen gel
To know more about our innovations and current research projects email our team below
Our Department of Scientific and Industrial Research (DSIR) approved ophthalmic, ENT & Skincare R&D Centre
A state-of-the-art facility for new molecular discovery, formulation development, personalised ophthalmic medicine and focus on areas such as biologicals, stem cell based therapies and gene therapies using the latest technology and generative AI.
Disclaimer: All products and therapies (both branded or generic) seen on this website can sold ONLY against the prescription of a registered medical practitioner (doctor) and NOT AVAILABLE to the general public for "Over the Counter (OTC)" purchase.
Copyright © 2024 ENTOD Pharmaceuticals - All Rights Reserved.
This website uses cookies. By continuing to use this site, you accept our use of cookies.